Air pollution exposure linked to higher COVID-19 cases and deaths – new study
Airlines got travelers comfortable about flying again once before – but 9/11 and a virus are a lot different
Macro Briefing | 13 July 2020
Racial disparities in COVID-19 are clear; better data, more targeted action needed
Moving To New Steady State
Comparing COVID-19 to past world war efforts is premature — and presumptuous
COVID-19 Research: Women Are Changing the Face of the Pandemic
Macro Dynamic Remains the Same but the Calendar gets Busy
What would it take to trigger a housing downturn in the second half of 2020?
Week Ahead – Bring on Earnings Season
Commentary in Pediatrics: Children don’t transmit Covid-19, schools should reopen in fall
Aerosols are a bigger coronavirus threat than WHO guidelines suggest – here's what you need to know
Altra Industrial Motion's (AIMC) Valuation Is Appealing, Says Analyst
Florida Reports Another 10k COVID-19 Cases As Dozens Of ICUs Are Overwhelmed: Live Updates
What will it take to achieve COVID-19 containment and economic revival?
Consolidation is the Flavor of the Day
Macro Briefing | 8 July 2020
WHO acknowledges ‘evidence emerging’ of airborne spread of COVID-19
3 ways to improve COVID-19 response to elderly care and persons with disabilities
Futures Fall As Europe Slides, Chinese Media Talks Back Rally
COVID-19: As offices reopen, here's what to expect if you're worried about getting sick on the job
Retractions and controversies over coronavirus research show that the process of science is working as it should
What makes a 'wave' of disease? An epidemiologist explains
The Danger of Benevolent Paternalism: Socialization and the Role of Government
Dominion, Duke Scrap Plans To Build $8B Atlantic Coast Gas Pipeline
Billionaire Buffett’s Energy Unit To Buy Dominion Energy Assets For $4B
As Pandemic Continues, World Health Organization Struggles To Maintain Coherent Response
E-scooters could disrupt travel as we know it – expect the car industry to fight back
Prices Are Going To Rise... And Fast!
U.S. FDA approves GSK’s HIV drug for patients with limited options